OR WAIT null SECS
November 03, 2024
Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.
November 01, 2024
CDER Director Patrizia Cavazzoni and CBER Director Peter Marks provided an update on the rare disease innovation hub in a new FDA Voices blog post.
The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.
With DKK 600 million (US$87.4 million) in funding from the Novo Nordisk Foundation, the new supercomputer offers the potential to accelerate innovation in drug discovery.
October 31, 2024
The treatment for ATTR in certain adults with polyneuropathy had just been recommended for approval across the European Union and had gained regulatory approval in the United States at the end of 2023.
A new laboratory will be built in Oss, while additional capacity and capabilities will be added to the Bioanalytical Center of Excellence in Assen.
Alec McChesney (BD Director, SCORR Marketing) discusses goal setting and alignment between life sciences marketing and business development teams.
The partnership will use ViaNautis’ proprietary polyNaut technology platform to develop genetic medicines that can precisely target tissue types.
October 30, 2024
The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.
October 29, 2024
WHO and its partners are providing support to countries dealing with mpox outbreaks.